Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression - Full Text View

Sponsored by:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00090506

Purpose

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

Condition	Intervention	Phase
HIV Infections Diabetes Depression	Behavioral: Yoga	Phase I

MedlinePlus related topics: AIDS Depression Diabetes

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Yoga, Health, and Meditation

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	50
Study Start Date:	July 2004
Study Completion Date:	March 2007
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)

Detailed Description:

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.

Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.

Eligibility

Ages Eligible for Study:	14 Years to 40 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria for Study 1 Participants:

Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

HIV infected
Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

Written informed consent of parent/guardian, if applicable

Exclusion Criteria for Study 2 Participants:

Require antiretroviral therapy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00090506

Locations

India
Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA)
Bangalore, India

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators

Principal Investigator:

Frederick M. Hecht, MD

UCSF Positive Health Program

More Information

Study ID Numbers:	R21 AT001942-01
Study First Received:	August 26, 2004
Last Updated:	January 23, 2008
ClinicalTrials.gov Identifier:	NCT00090506
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Yoga
Meditation

Study placed in the following topic categories:

Sexually Transmitted Diseases, Viral
Metabolic Diseases
Depression
Acquired Immunodeficiency Syndrome
Diabetes Mellitus
Endocrine System Diseases
Depressive Disorder
Immunologic Deficiency Syndromes
Behavioral Symptoms

Virus Diseases
HIV Infections
Mental Disorders
Sexually Transmitted Diseases
Mood Disorders
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders
Retroviridae Infections

Additional relevant MeSH terms:

RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 14, 2009